Kathleen Tregoning
Director/Board Member en SPERO THERAPEUTICS, INC. .
Fortuna: 450 852 $ al 31/03/2024
Perfil
Kathleen Tregoning is currently an Independent Director at Spero Therapeutics, Inc. since 2021 and the Chief Corporate Affairs Officer at Cerevel Therapeutics Holdings, Inc. since 2020.
Previously, she served as the Executive Vice President-External Affairs at Sanofi from 2017 to 2020.
She also held the position of Senior Vice President-Corporate Affairs at Biogen France SAS.
Ms. Tregoning completed her undergraduate degree at Stanford University and her graduate degree at Harvard Kennedy School of Government.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
19/01/2024 | 10 666 ( 0.01% ) | 450 852 $ | 31/03/2024 | |
SPERO THERAPEUTICS, INC.
-.--% | 08/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Cargos activos de Kathleen Tregoning
Empresas | Cargo | Inicio |
---|---|---|
CEREVEL THERAPEUTICS HOLDINGS, INC. | Public Communications Contact | 01/07/2020 |
SPERO THERAPEUTICS, INC. | Director/Board Member | 11/10/2021 |
Antiguos cargos conocidos de Kathleen Tregoning.
Empresas | Cargo | Fin |
---|---|---|
SANOFI | Public Communications Contact | 01/03/2020 |
Biogen France SAS
Biogen France SAS BiotechnologyHealth Technology Biogen France SAS engages in research and development of biotechnology. The company was founded in 1994 and is headquartered in Paris, France. | Corporate Officer/Principal | - |
Formación de Kathleen Tregoning.
Stanford University | Undergraduate Degree |
Harvard Kennedy School of Government | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
SANOFI | Health Technology |
SPERO THERAPEUTICS, INC. | Health Technology |
CEREVEL THERAPEUTICS HOLDINGS, INC. | Health Technology |
Empresas privadas | 1 |
---|---|
Biogen France SAS
Biogen France SAS BiotechnologyHealth Technology Biogen France SAS engages in research and development of biotechnology. The company was founded in 1994 and is headquartered in Paris, France. | Health Technology |
- Bolsa de valores
- Insiders
- Kathleen Tregoning